1) Unitary Patent system
European commission published two draft two legislative proposals on unitary patent as 25 out of 27 EU member states agreed. The draft regulations will now pass to the Council and the European Parliament for consideration.
2) Govt plans to make public details of patented drugs [ET]
The details that would be made publicly available would be particularly useful for health activists and generic drugmakers to check whether patent holders are using their sole marketing rights to meet medicine demand of patients. If not, a generic drugmaker can seek ‘compulsory licensing’, a provision that allows generic company to legally make and sell cheaper version of the medicine under certain conditions.